{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:54678486",
      "entity_text" : "warfarin",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:5462224",
      "entity_text" : "mg",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : true
  },
  "verbose_text" : "Studies have suggested that oral (1.0-5.0 mg) or intravenous (0.5-2.0 mg) vitamin K can be administered to reverse the anticoagulant effects of warfarin [XREF_BIBR, XREF_BIBR].",
  "reading_complete" : "2020-08-03T11:30:10Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T11:26:44Z",
  "trigger" : "reverse",
  "evidence" : [ "mg) vitamin K can be administered to reverse the anticoagulant effects of warfarin" ],
  "pmc_id" : "4418784",
  "score" : 0
}